Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Biological markers associated to increased coronary artery calcifications after adjustment for age, gender, diabetes mellitus and smoking (the p-value of the test for trend is given). | Coronary artery calcifications | | Coronary artery calcifications | | <100 (n = 79) | [100 to 400[ (n = 50) | ≥400 (n = 66) | | [100 to 400[ vs <100 | ≥400 vs <100 | Variable | n | % | n | % | n | % | Global P-value | OR [CI 95%] | OR [CI 95%]: 1.25 (OH)2 vitamin D (pg/mL) | | | | | | | | |
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
195 ND-CKD patients (112 males/83 females, 70.8 [27.4 to 94.6] years) were enrolled in this cross-sectional study.
Source: Abstract.
In the case of FGF23 and OPG, patients were divided into two categories, those with a low level (<173.30 RU/mL for FGF23; <10.71 pmol/L for OPG, corresponding to the 1st and 2nd tertiles) and those with a high level (≥173.30 RU/mL for FGF23; ≥10.71 pmol/L for OPG, corresponding to the 3rd tertile).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients
Cross-sectional study · PLoS ONE · 2012
Original publication title
Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients
Morena et al.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? OPG?
Source: BackgroundAbstract: Methodology/Principal Findings
195 ND-CKD patients (112 males/83 females, 70.8 [27.4 to 94.6] years) were enrolled in this cross-sectional study. All underwent chest multidetector computed tomography for CAC scoring. Vascular risk markers including FGF23 and OPG were measured. Logistic regression analyses were used to study the potential relationships between CAC and these markers.
The fully adjusted-univariate analysis clearly showed high OPG (≥10.71 pmol/L) as the only variable significantly associated with moderate CAC ([100 to 400[) (OR = 2.73 [1.03;7.26]; p = 0.04). Such association failed to persist for CAC scoring higher than 400. Indeed, severe CAC was only associated with high phosphate fractional excretion (FEPO4) (≥38.71%) (OR = 5.47 [1.76;17.0]; p = 0.003) and high FGF23 (≥173.30 RU/mL) (OR = 5.40 [1.91;15.3]; p = 0.002). In addition, the risk to present severe CAC when FGF23 level was high was not significantly different when OPG was normal or high.
Conversely, the risk to present moderate CAC when OPG level was high was not significantly different when FGF23 was normal or high.
Source: Methodology/Principal Findings Source: Methodology/Principal FindingsAbstract: Conclusions
Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.
Source: ConclusionsAuthors’ abstract
Background
Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? OPG?
Methodology/Principal Findings
195 ND-CKD patients (112 males/83 females, 70.8 [27.4 to 94.6] years) were enrolled in this cross-sectional study. All underwent chest multidetector computed tomography for CAC scoring. Vascular risk markers including FGF23 and OPG were measured. Logistic regression analyses were used to study the potential relationships between CAC and these markers.
The fully adjusted-univariate analysis clearly showed high OPG (≥10.71 pmol/L) as the only variable significantly associated with moderate CAC ([100 to 400[) (OR = 2.73 [1.03;7.26]; p = 0.04). Such association failed to persist for CAC scoring higher than 400. Indeed, severe CAC was only associated with high phosphate fractional excretion (FEPO4) (≥38.71%) (OR = 5.47 [1.76;17.0]; p = 0.003) and high FGF23 (≥173.30 RU/mL) (OR = 5.40 [1.91;15.3]; p = 0.002). In addition, the risk to present severe CAC when FGF23 level was high was not significantly different when OPG was normal or high.
Conversely, the risk to present moderate CAC when OPG level was high was not significantly different when FGF23 was normal or high.
Conclusions
Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.
Publication and source details
Original title: Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients
Marion Morena; Isabelle Jaussent; Aurore Halkovich; Anne-Marie Dupuy; Anne-Sophie Bargnoux; Leila Chenine; Hélène Leray-Moragues; Kada Klouche; Hélène Vernhet; Bernard Canaud; Jean-Paul Cristol
PLoS ONE · 2012
* E-mail: jp-cristol@chu-montpellier.frConceived and designed the experiments: MM AMD KK HV BC JPC. Performed the experiments: MM AH AMD ASB LC HLM KK HV BC JPC. Analyzed the data: MM IJ AMD BC JPC . Wrote the paper: MM IJ BC JPC . Reviewed, revised and approved the final paper: MM IJ AH AMD ASB LC HLM KK HV BC JPC.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T21:10:36.371533+00:00
DOI: 10.1371/journal.pone.0036175 · PMC3342257